Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.36) by 42.06 percent. This is a 15 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $43.000 thousand which missed the analyst consensus estimate of $215.615 thousand by 80.06 percent. This is a 81.62 percent decrease over sales of $234.000 thousand the same period last year.